Nectar Lifescience Ltd

About [ edit ]

Nectar Lifesciences a pharmaceutical company, primarily engages in the development, manufacture, and marketing of various active pharmaceutical ingredients (APIs) and finished dosage forms.

  • Market Cap 436 Cr.
  • Current Price 19.4
  • High / Low 30.0 / 11.8
  • Stock P/E
  • Book Value 49.5
  • Dividend Yield 0.26 %
  • ROCE 8.22 %
  • ROE 2.66 %
  • Face Value 1.00

Pros

  • Stock is trading at 0.39 times its book value
  • Debtor days have improved from 84.78 to 61.39 days.

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 7.57% over past five years.
  • Company has a low return on equity of 4.00% for last 3 years.
  • Dividend payout has been low at 2.75% of profits over last 3 years
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
593.27 532.74 722.50 731.24 798.54 579.55 570.50 652.51 560.61 388.43 427.73 377.98
542.05 472.67 658.64 665.56 724.17 517.76 523.21 595.87 508.01 371.70 396.26 345.22
Operating Profit 51.22 60.07 63.86 65.68 74.37 61.79 47.29 56.64 52.60 16.73 31.47 32.76
OPM % 8.63% 11.28% 8.84% 8.98% 9.31% 10.66% 8.29% 8.68% 9.38% 4.31% 7.36% 8.67%
Other Income 1.27 1.31 1.45 1.53 1.66 2.13 1.19 0.58 0.11 0.52 0.53 0.66
Interest 30.17 29.92 43.55 36.00 38.66 31.47 32.68 31.07 30.60 27.87 27.88 30.63
Depreciation 16.17 16.29 15.55 16.88 14.54 16.40 13.77 15.23 15.36 15.05 15.09 15.10
Profit before tax 6.15 15.17 6.21 14.33 22.83 16.05 2.03 10.92 6.75 -25.67 -10.97 -12.31
Tax % 36.75% 12.99% 13.37% 21.07% 23.74% 15.83% 6.90% 18.77% 14.07% 34.44% 33.36% 34.52%
Net Profit 3.89 13.20 5.39 11.32 17.41 13.50 1.89 8.87 5.80 -16.82 -7.31 -8.06
EPS in Rs 0.17 0.59 0.24 0.50 0.78 0.60 0.08 0.40 0.26 -0.75 -0.33 -0.36

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
725 843 1,060 1,312 1,622 1,634 1,638 1,675 1,635 1,873 2,781 2,360 1,755
583 648 831 1,062 1,332 1,345 1,371 1,436 1,411 1,637 2,517 2,142 1,621
Operating Profit 142 195 229 250 290 289 267 239 224 236 264 218 134
OPM % 20% 23% 22% 19% 18% 18% 16% 14% 14% 13% 10% 9% 8%
Other Income 4 19 11 12 16 12 20 6 23 6 6 4 2
Interest 50 60 74 115 115 138 126 123 117 115 148 126 117
Depreciation 30 39 46 61 76 84 77 57 62 64 63 61 61
Profit before tax 66 115 120 85 115 78 85 64 67 63 59 36 -42
Tax % 17% 20% 14% 14% 25% 21% 22% 15% 18% 17% 19% 16%
Net Profit 55 92 104 73 86 62 66 54 55 52 47 30 -26
EPS in Rs 3.58 4.10 4.63 3.27 3.82 2.77 2.95 2.42 2.46 2.33 2.11 1.34 -1.18
Dividend Payout % 3% 6% 2% 3% 3% 4% 3% 4% 2% 2% 2% 4%
Compounded Sales Growth
10 Years:11%
5 Years:8%
3 Years:13%
TTM:-33%
Compounded Profit Growth
10 Years:-10%
5 Years:-15%
3 Years:-18%
TTM:-163%
Stock Price CAGR
10 Years:-4%
5 Years:-13%
3 Years:-11%
1 Year:27%
Return on Equity
10 Years:7%
5 Years:5%
3 Years:4%
Last Year:3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
15 22 22 22 22 22 22 22 22 22 22 22 22
Reserves 288 599 699 762 845 905 936 932 984 1,036 1,082 1,112 1,087
Borrowings 704 601 796 1,043 879 858 925 962 878 955 903 779 783
283 259 295 293 527 609 628 640 696 710 696 719 641
Total Liabilities 1,290 1,481 1,813 2,121 2,274 2,394 2,510 2,557 2,581 2,724 2,704 2,632 2,534
526 627 736 858 914 948 934 906 881 852 825 785 765
CWIP 74 56 82 150 139 122 91 99 102 100 100 115 115
Investments 6 26 5 0 0 0 1 1 1 1 1 1 1
684 772 989 1,113 1,221 1,324 1,485 1,551 1,597 1,771 1,778 1,732 1,653
Total Assets 1,290 1,481 1,813 2,121 2,274 2,394 2,510 2,557 2,581 2,724 2,704 2,632 2,534

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
134 -92 44 165 361 255 144 169 199 65 239 286
-184 -145 -165 -234 -99 -90 -60 -77 -18 -29 -26 -33
58 234 123 62 -282 -161 -61 -89 -204 -40 -201 -252
Net Cash Flow 8 -4 2 -7 -20 4 23 3 -24 -4 12 1

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 13% 15% 14% 12% 13% 12% 11% 10% 10% 9% 10% 8%
Debtor Days 84 96 107 85 79 84 99 107 112 119 74 61
Inventory Turnover 1.87 1.54 1.72 1.79 1.90 1.70 1.58 1.55 1.45 1.73 2.62 2.06

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
55.80 55.80 55.80 55.80 55.80 55.80 55.80 55.80 55.80 55.80 55.80 55.80
3.29 2.94 2.90 2.90 2.90 2.90 2.90 2.90 2.90 2.90 2.62 2.62
0.34 0.09 0.05 0.10 0.10 0.01 0.03 0.00 0.00 0.00 0.00 0.00
40.57 41.17 41.25 41.20 41.20 41.29 41.27 41.30 41.30 41.30 41.58 41.58

Documents